Study guide

12.1 ECMO Candidacy & Modality

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

12.1 ECMO Candidacy & Modality

Key Takeaways Explain This Topic AI

ECMO is considered for potentially reversible or bridgeable cardiopulmonary failure despite optimized conventional and rescue therapy. Refer or consult early; oxygenation index and trajectory support the decision but no single number automatically determines cannulation.

VV ECMO supports gas exchange and requires adequate native cardiac function; VA ECMO provides gas exchange plus direct circulatory support. Cannulation strategy and contraindications are patient-, anatomy-, center-, and era-specific.

Oxygenation index equals (mean airway pressure x FiO2 x 100) divided by PaO2; a persistent value near or above 40 is a traditional high-risk signal for urgent ECMO-center consultation rather than an automatic cannulation order.

Neonatal VV ECMO commonly uses a single bicaval dual-lumen catheter in the right internal jugular vein, and recirculation of newly oxygenated blood back into the drainage port limits its oxygenation efficiency.

Last updated: September 2026

12.1 ECMO Candidacy & Modality

Extracorporeal Membrane Oxygenation (ECMO) is a specialized form of cardiopulmonary bypass engineered to provide temporary, life-sustaining extracorporeal gas exchange and hemodynamic perfusion for neonates and children suffering from refractory, life-threatening cardiopulmonary failure. ECMO does not cure the underlying disease; it buys time for recovery or definitive intervention and permits reduction of injurious ventilator and oxygen exposure.

Indications & Clinical Entry Criteria

ECMO carries substantial procedural, neurologic, infectious, and hematologic risk. Consider it when potentially reversible or bridgeable cardiopulmonary failure continues despite optimized conventional and rescue therapy. Consultation should occur before irreversible organ injury; the final decision integrates trajectory, diagnosis, anatomy, comorbidities, bleeding risk, goals of care, and the receiving center’s criteria.

Primary Clinical Indications in Neonates and Children

Severe Neonatal Acute Hypoxemic Respiratory Failure:

  • Persistent Pulmonary Hypertension of the Newborn (PPHN)
  • Meconium Aspiration Syndrome (MAS)
  • Congenital Diaphragmatic Hernia (CDH) (pre-operative stabilization or post-operative rescue)
  • Severe Neonatal Respiratory Distress Syndrome (RDS)
  • Neonatal Sepsis / Sepsis-Induced Cardiomyopathy

Pediatric Acute Respiratory Failure:

Severe Pediatric Acute Respiratory Distress Syndrome (PARDS) refractory to prone positioning, neuromuscular blockade, and high-frequency ventilation

  • Severe viral pneumonia (e.g., respiratory syncytial virus, influenza, adenovirus)
  • Status asthmaticus with intractable hypercapnic respiratory acidosis and dynamic hyperinflation
  • Massive pulmonary hemorrhage or severe aspiration syndromes

Refractory Cardiogenic Shock / Extracorporeal Cardiopulmonary Resuscitation (E-CPR):

Acute fulminant viral myocarditis

Post-cardiotomy low cardiac output syndrome (failure to wean from cardiopulmonary bypass after congenital heart surgery)

  • Intractable ventricular arrhythmias or cardiomyopathy
  • In-hospital cardiac arrest refractory to standard PALS resuscitation (E-CPR)
  • Oxygenation Index (OI): A Severity and Trajectory Metric

In neonates with hypoxemic respiratory failure, OI combines the mean airway pressure required for support with arterial oxygenation. Serial values can prompt early ECMO-center consultation, but OI is not an automatic cannulation order: O I = mPAW × F i O 2 × 100 P a O 2 OI = \frac{\text{mPAW} \times FiO_2 \times 100}{PaO_2} O I = P a O 2 ​ mPAW × F i O 2 ​ × 100 ​

Where:

mPAW \text{mPAW} mPAW is Mean Airway Pressure in cmH 2 O \text{cmH}_2\text{O} cmH 2 ​ O

F i O 2 FiO_2 F i O 2 ​ is the Fraction of Inspired Oxygen (expressed as a decimal from 0.21 to 1.0 0.21\text{ to }1.0 0.21 to 1.0 )

P a O 2 PaO_2 P a O 2 ​ is Arterial Partial Pressure of Oxygen in mmHg \text{mmHg} mmHg obtained from a pre-ductal or post-ductal arterial line +-----------------------------------------------------------------------------+

  • | WHEN TO CONTACT AN ECMO CENTER EARLY |
  • +-----------------------+-----------------------------------------------------+
  • | Signal | Interpretation |
  • +-----------------------+-----------------------------------------------------+
  • | Rising OI / high | Persistent values near or above 40 are traditional |
  • | support intensity | high-risk signals, not automatic cannulation rules. |
  • +-----------------------+-----------------------------------------------------+
  • | Refractory gas | Recheck airway, circuit, recruitment, hemodynamics, |
  • | exchange or acidosis | disease treatment, and reversibility while calling. |
  • +-----------------------+-----------------------------------------------------+
  • | Worsening perfusion | Rising lactate, oliguria, ventricular dysfunction, |
  • | or organ function | or shock increases urgency and affects modality. |
  • +-----------------------+-----------------------------------------------------+
  • | Patient context | Anatomy, neurologic and bleeding risk, duration of |
  • | | injury, goals, transport, and center criteria decide.|
  • +-----------------------+-----------------------------------------------------+
  • Contraindications to Extracorporeal Life Support

ECMO candidacy requires explicit risk-benefit review. The factors below have traditionally limited neonatal or pediatric ECMO, but many are relative rather than universal exclusions and thresholds vary by center, equipment, diagnosis, and evolving practice: +-----------------------------------------------------------------------------+

  • | FACTORS THAT MAY LIMIT NEONATAL/PEDIATRIC ECMO |
  • +-----------------------+-----------------------------------------------------+
  • | Risk factor | Why it may limit candidacy |
  • +-----------------------+-----------------------------------------------------+
  • | Gestational Age | Extreme fragility of the germinal matrix vessels; |
  • | < 34 Weeks | Germinal-matrix fragility raises intracranial |
  • | | bleeding risk; current center criteria apply. |
  • +-----------------------+-----------------------------------------------------+
  • | Birth Weight | Peripheral and central vessels are too small to |
  • | < 1.8 to 2.0 kg | Cannula size and achievable flow may limit support; |
  • | | thresholds depend on equipment and center outcomes. |
  • +-----------------------+-----------------------------------------------------+
  • | Severe Intracranial | Severe or expanding hemorrhage can make |
  • | Bleeding | anticoagulation and cannulation risk unacceptable; |
  • | | review imaging, trajectory, and center criteria. |
  • +-----------------------+-----------------------------------------------------+
  • | Genetic or structural| Prognosis, reversibility, goals of care, and |
  • | conditions | potential benefit require individualized review. |
  • +-----------------------+-----------------------------------------------------+
  • | Prolonged Mechanical | Longer exposure to injurious ventilation may reduce |
  • | Ventilation | reversibility; duration is not a stand-alone cutoff. |
  • +-----------------------+-----------------------------------------------------+
  • | Uncontrolled Systemic | Massive active intracranial or visceral bleeding |
  • | Hemorrhage | that cannot be surgically controlled. |
  • +-----------------------+-----------------------------------------------------+
  • ECMO Modalities: Venoarterial (VA) vs. Venovenous (VV)

Selecting the appropriate ECMO modality depends entirely on whether the patient requires pulmonary gas exchange support alone or combined cardiopulmonary and hemodynamic support . +-----------------------------------------------------------------------------+

  • | VA ECMO VS. VV ECMO ARCHITECTURE |
  • +-----------------------------------------------------------------------------+
  • | |
  • | [ VENOARTERIAL (VA) ECMO ] [ VENOVENOUS (VV) ECMO ] |
  • | Total Cardiopulmonary Support Isolated Pulmonary Gas Exchange|
  • | |
  • | Drainage: Right Internal Jugular Drainage: Right Internal |
  • | Vein (Right Atrium) Jugular (Caval ports)|
  • | | | |
  • | v v |
  • | +-----------------------+ +-----------------------+ |
  • | | Pump + Membrane Lung | | Pump + Membrane Lung | |
  • | +-----------------------+ +-----------------------+ |
  • | | | |
  • | v v |
  • | Reinfusion: Right Common Carotid Reinfusion: Right Atrium via |
  • | Artery (Aorta) Dual-Lumen Avalon |
  • | | | |
  • | v v |
  • | Systemic Arterial Circulation Right Heart -> Native Lungs |
  • | (Non-pulsatile, bypasses heart & lungs) (Pulsatile, heart does work) |
  • | |
  • +-----------------------------------------------------------------------------+
  • 1. Venoarterial (VA) ECMO

Cannulation sites: Neonatal peripheral VA ECMO often drains the right internal jugular vein and returns to the right carotid artery. Central or other peripheral configurations are possible according to size, anatomy, prior surgery, urgency, and center expertise. Carotid management may involve ligation or reconstruction.

Physiological action: VA ECMO returns oxygenated blood to the arterial circulation and provides direct circulatory plus gas-exchange support. Native heart and lung flow may continue, so the degree of bypass and pulsatility depends on ECMO flow and native function.

Cardiovascular consequences: Arterial reinfusion can increase left-ventricular afterload and distension; monitor pulsatility, ventricular ejection, pulmonary edema, and the need for unloading.

Risks and complications: Bleeding, vascular injury, limb or cerebral ischemia, thromboembolism, infection, hemolysis, differential oxygenation in some configurations, and neurologic injury require continuous surveillance.

2. Venovenous (VV) ECMO

Cannulation Sites: Modern neonatal and pediatric VV ECMO is predominantly accomplished using a single bicaval dual-lumen catheter (e.g., Avalon Elite or OriGen catheter) placed surgically or percutaneously into the right internal jugular vein . The drainage ports open in the superior vena cava and inferior vena cava, while the reinfusion port directs oxygenated blood across the tricuspid valve into the right atrium. In older children, two separate cannulas may be placed (drainage from femoral vein, reinfusion into internal jugular vein).

Physiological Action: VV ECMO drains systemic venous blood, oxygenates and decarbondioxylates it, and returns it directly back into the venous circulation. Blood then flows through the patient's native right ventricle, pulmonary vascular bed, and left heart. VV ECMO provides pulmonary gas exchange only; it provides NO direct cardiac output support. The patient's native myocardium must be capable of generating adequate cardiac output and maintaining blood pressure.

Physiological features: VV support avoids an arterial return cannula and preserves native cardiac ejection and pulsatility. It generally has less direct systemic-embolization risk than VA, but embolic, thrombotic, cannulation, recirculation, hemolysis, and neurologic complications remain possible, especially with intracardiac shunts or circuit failure.

Unique Limitation: Recirculation: A fraction of newly oxygenated blood exiting the reinfusion port is immediately drawn back into the drainage port without passing through the systemic circulation, reducing oxygenation efficiency.

Clinical Comparison: VA vs. VV ECMO

  • Operational Feature Venoarterial (VA) ECMO Venovenous (VV) ECMO
  • Organ Systems Supported Heart AND Lungs (Cardiopulmonary) Lungs ONLY (Isolated Pulmonary)
  • Myocardial Function Required Can be severely depressed or absent Must be intact and functioning

Cannulation Sites (Neonatal) Right Internal Jugular Vein + Right Carotid Artery Right Internal Jugular Vein (Dual-Lumen Catheter)

  • Carotid Artery May be cannulated, ligated, or reconstructed in a neck approach No arterial return cannula
  • Arterial Pulsatility Depends on native ejection and ECMO flow Usually maintained by native ejection

Oxygen Delivery to Coronary Vessels Retrograde flow from aortic cannula Antegrade flow from native left ventricle

Systemic embolic considerations Direct arterial return adds arterial embolic risk No arterial return cannula, but embolic and neurologic events remain possible

Primary Clinical Indication Cardiac arrest (E-CPR), post-cardiotomy, septic shock Isolated RDS, MAS, PPHN with stable myocardium